JD Health International Inc.
6618
Rangering i aksjer
#1395
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Aksjekurs
$4.90
Markedsverdi
$15.64B
Endring (1 dag)
-1.18%
Endring (1 år)
-38.42%
Land
CN
Handel JD Health International Inc. (6618)
Kategori
Healthcare
Inntekter for JD Health International Inc. (6618)
Inntekter i Jun 2026 TTM: $11.37B
Ifølge de nyeste økonomiske rapportene til JD Health International Inc. er selskapets nåværende inntekter (TTM) $11.37B. I 2023 hadde selskapet inntekter på $7.56B en økning sammenlignet med inntektene i 2022, som var $6.78B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for JD Health International Inc. fra 2017 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $11.37B | 42.72% |
| 2024 | $7.97B | 5.37% |
| 2023 | $7.56B | 11.61% |
| 2022 | $6.78B | 40.35% |
| 2021 | $4.83B | 62.70% |
| 2020 | $2.97B | 90.55% |
| 2019 | $1.56B | 31.11% |
| 2018 | $1.19B | 39.14% |
| 2017 | $853.51M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $78.01B | 586.00% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 91.80% |
US
|
|
| $3.89B | -65.75% |
SA
|
|
| $11.08B | -2.53% |
BR
|
